A detailed history of Tompkins Financial Corp transactions in Viatris Inc stock. As of the latest transaction made, Tompkins Financial Corp holds 2,035 shares of VTRS stock, worth $22,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,035
Previous 1,473 38.15%
Holding current value
$22,792
Previous $17,000 47.06%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

BUY
$11.32 - $13.37 $6,361 - $7,513
562 Added 38.15%
2,035 $25,000
Q3 2024

Nov 01, 2024

SELL
$10.32 - $12.13 $5,056 - $5,943
-490 Reduced 24.96%
1,473 $17,000
Q2 2024

Jul 17, 2024

SELL
$10.05 - $12.02 $3,577 - $4,279
-356 Reduced 15.35%
1,963 $20,000
Q1 2024

Apr 08, 2024

SELL
$11.27 - $13.53 $9,432 - $11,324
-837 Reduced 26.52%
2,319 $27,000
Q4 2023

Jan 08, 2024

BUY
$8.77 - $10.85 $3,008 - $3,721
343 Added 12.19%
3,156 $34,000
Q1 2023

Apr 20, 2023

SELL
$9.2 - $12.26 $2,318 - $3,089
-252 Reduced 8.22%
2,813 $27,000
Q4 2022

Jan 06, 2023

SELL
$8.72 - $11.56 $915 - $1,213
-105 Reduced 3.31%
3,065 $34,000
Q3 2022

Oct 13, 2022

BUY
$8.48 - $11.13 $4,324 - $5,676
510 Added 19.17%
3,170 $27,000
Q2 2022

Jul 14, 2022

SELL
$9.95 - $12.27 $7,681 - $9,472
-772 Reduced 22.49%
2,660 $28,000
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $24,495 - $38,453
2,497 Added 267.06%
3,432 $37,000
Q4 2021

Jan 24, 2022

SELL
$12.09 - $14.68 $9,575 - $11,626
-792 Reduced 45.86%
935 $13,000
Q3 2021

Oct 22, 2021

SELL
$13.25 - $15.13 $3,935 - $4,493
-297 Reduced 14.67%
1,727 $23,000
Q1 2021

Jun 09, 2021

SELL
$13.59 - $18.54 $326 - $444
-24 Reduced 1.17%
2,024 $28,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $29,286 - $38,379
2,048 New
2,048 $38,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Tompkins Financial Corp Portfolio

Follow Tompkins Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.